190 related articles for article (PubMed ID: 15979927)
1. Treatment of Gorham's disease with zoledronic acid.
Mignogna MD; Fedele S; Lo Russo L; Ciccarelli R
Oral Oncol; 2005 Aug; 41(7):747-50. PubMed ID: 15979927
[TBL] [Abstract][Full Text] [Related]
2. Use of zoledronic acid in the treatment of Gorham's disease.
Avelar RL; Martins VB; Antunes AA; de Oliveira Neto PJ; Andrade ES
Int J Pediatr Otorhinolaryngol; 2010 Mar; 74(3):319-22. PubMed ID: 20074817
[TBL] [Abstract][Full Text] [Related]
3. Gorham's disease of the mandible mimicking periodontal disease on radiograph.
Mignogna MD; Fedele S; Lo Russo L; Lanza A; Marenzi G; Sammartino G
J Clin Periodontol; 2005 Sep; 32(9):1022-6. PubMed ID: 16104969
[TBL] [Abstract][Full Text] [Related]
4. Commentary: Massive osteolysis or Gorham-Stout disease.
Migliorati CA
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Feb; 109(2):242-3. PubMed ID: 20123408
[No Abstract] [Full Text] [Related]
5. A case of vanishing skull: Gorham's disease.
Zhao S; Richardson D; Mahindrakar M; Nair JR
Rheumatology (Oxford); 2017 Aug; 56(8):1311. PubMed ID: 28854618
[No Abstract] [Full Text] [Related]
6. Phase II trial evaluating the palliative benefit of second-line zoledronic acid in breast cancer patients with either a skeletal-related event or progressive bone metastases despite first-line bisphosphonate therapy.
Clemons MJ; Dranitsaris G; Ooi WS; Yogendran G; Sukovic T; Wong BY; Verma S; Pritchard KI; Trudeau M; Cole DE
J Clin Oncol; 2006 Oct; 24(30):4895-900. PubMed ID: 17001071
[TBL] [Abstract][Full Text] [Related]
7. Zoledronic acid to prevent skeletal complications in cancer: corroborating the evidence.
Smith MR
Cancer Treat Rev; 2005; 31 Suppl 3():19-25. PubMed ID: 16229955
[TBL] [Abstract][Full Text] [Related]
8. Management of massive osteolysis of the mandible: a case report.
Tong AC; Leung TM; Cheung PT
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Feb; 109(2):238-41. PubMed ID: 20034823
[TBL] [Abstract][Full Text] [Related]
9. Use of zoledronic acid combined with thalidomide in the treatment of Gorham-Stout disease.
Mao T; Xu L; Yu Y; Li Z; Sheng J
Rheumatology (Oxford); 2018 Jun; 57(6):1122-1124. PubMed ID: 29554344
[No Abstract] [Full Text] [Related]
10. Optimal management of metastatic bone disease.
Major P
Eur J Oncol Nurs; 2007; 11 Suppl 2():S32-7. PubMed ID: 17804294
[TBL] [Abstract][Full Text] [Related]
11. Is a single infusion of zoledronic acid more effective than oral risedronate for the treatment of patients with Paget's disease?
Krane SM
Nat Clin Pract Rheumatol; 2006 Apr; 2(4):186-7. PubMed ID: 16932682
[No Abstract] [Full Text] [Related]
12. Massive osteolysis in a dog resembling Gorham's disease in humans.
Farrell M; Lindsay S; Johnson V; Child G
Vet Comp Orthop Traumatol; 2011; 24(5):389-97. PubMed ID: 21822531
[TBL] [Abstract][Full Text] [Related]
13. A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg.
Abelson A
Curr Med Res Opin; 2008 Mar; 24(3):695-705. PubMed ID: 18226324
[TBL] [Abstract][Full Text] [Related]
14. Gorham's disease: 99mTc HMDP bone scan findings.
López Vélez L; Navarro P; Rodríguez Chacón L; Sanz Moncasi P; Liévano P; De La Cueva L
Rev Esp Med Nucl Imagen Mol; 2012 Sep; 31(5):292-4. PubMed ID: 23067536
[No Abstract] [Full Text] [Related]
15. A multicenter, randomized clinical trial comparing zoledronic acid versus observation in patients with asymptomatic myeloma.
Musto P; Petrucci MT; Bringhen S; Guglielmelli T; Caravita T; Bongarzoni V; Andriani A; D'Arena G; Balleari E; Pietrantuono G; Boccadoro M; Palumbo A;
Cancer; 2008 Oct; 113(7):1588-95. PubMed ID: 18683218
[TBL] [Abstract][Full Text] [Related]
16. Temporary paraplegia resulting from Gorham's disease involving the third lumbar vertebra and proximal femur: a five-year follow-up and review of the literature.
Esmailiejah AA; Kamalian N; Abbasian M
Arch Iran Med; 2013 Nov; 16(11):686-90. PubMed ID: 24206415
[TBL] [Abstract][Full Text] [Related]
17. Management of cancer-treatment-induced bone loss in postmenopausal women undergoing adjuvant breast cancer therapy: a Z-FAST update.
Brufsky A
Semin Oncol; 2006 Apr; 33(2 Suppl 7):S13-7. PubMed ID: 16730272
[TBL] [Abstract][Full Text] [Related]
18. Integrated analysis of zoledronic acid for prevention of aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole.
Brufsky A; Bundred N; Coleman R; Lambert-Falls R; Mena R; Hadji P; Jin L; Schenk N; Ericson S; Perez EA;
Oncologist; 2008 May; 13(5):503-14. PubMed ID: 18515735
[TBL] [Abstract][Full Text] [Related]
19. Preliminary evidence for a structural benefit of the new bisphosphonate zoledronic acid in early rheumatoid arthritis.
Jarrett SJ; Conaghan PG; Sloan VS; Papanastasiou P; Ortmann CE; O'Connor PJ; Grainger AJ; Emery P
Arthritis Rheum; 2006 May; 54(5):1410-4. PubMed ID: 16645968
[TBL] [Abstract][Full Text] [Related]
20. Anti-tumour activity of zoledronic acid.
Clézardin P
Cancer Treat Rev; 2005; 31 Suppl 3():1-8. PubMed ID: 16225995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
